UCD Foundation is pleased to announce that Shire plc, the global biotechnology leader in rare diseases, are supporting an academic scholarship programme for student’s undertaking the Masters in Biopharmaceutical Engineering in University College Dublin (UCD).
The scholarship, which will run from 2018 through to 2020, will be awarded to the top performing students each year. Separately, there will also be a prize funded by Shire for the best Bioprocess Engineering Design Project, submitted in semester 3 by a team of students.
Susan Hynes, Site Lead for Shire Dunboyne, said: “We are delighted to announce this collaboration with UCD’s Masters in Biopharmaceutical Engineering. Shire is committed to support the drive to expand skills and talent. This is essential in order to meet the demand for high calibre graduates in Ireland’s growing Biopharma sector and this university programme is a great way of doing this. This is key for us as we continue to build our presence in Ireland with our state-of-the-art biologics facility in Dunboyne.”
The Biopharmaceutical MEngSC Engineering programme provides intensive training for a professional engineer or scientist in the biopharmaceutical sector. The course content addresses the principal scientific and engineering challenges involved in the design, operation and management of biopharmaceutical production facilities today.
The scholarship will be awarded upon graduation in December, for both the individuals and design project teams.